News Enbrel unlikely to face Novartis rival until 2018 Amgen arguing that US patent will last until 2029.
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Court bans US sales of Sanofi cholesterol drug Amgen looks to corner PCSK9 market after patent win.
News Novartis faces bribery probe in Greece Prosecutors raid Athens offices, according to press reports.
News US fines Teva $519m over foreign bribery charges Teva admits it bribed officials in Russia, Ukraine and Mexico.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
